Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A live-attenuated vaccine designed to provide broader, serotype-independent protection against pneumococcal infections. This vaccine aims to address the limitations of existing capsule-targeted vaccines and combat diseases caused by *Streptococcus pneumoniae*, including pneumonia, acute otitis media, acute sinusitis, and invasive diseases, which are a leading cause of pediatric death. Blue Water Vaccines licensed the patent rights for global development from St. Jude Children's Research Hospital.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Live-attenuated Streptococcus pneumoniae vaccine.